CAMP - NASDAQ

CAMP4 Therapeutics Corporation

CAMP·NASDAQ

$4.37

+4.8%

HealthcareBiotechnology

CAMP4 Therapeutics Corp. operates as a biotechnology company which engages in the discovery of treatment options for patients. The company was founded by Richard A. Young and Leonard Zon in 2015 and is headquartered in Cambridge, MA.

Statements Value Model

At a Glance

Live Snapshot

Market Cap$92.82M

EPS-2.6500

P/E Ratio-1.65

Earnings Date08/13/2026

camp

Total Liabilities and Equity

Last Annual Value

117.81M

3-Year CAGR

5-Year CAGR

-23%

10-Year CAGR

-11%

Adjust for Inflation

CAMP4 Therapeutics Corporation Competitors Analysis of Total Liabilities and Equity

CAMP · NASDAQ

Company	Total Liabilities and Equity	CAGR 3Y	CAGR 5Y	CAGR 10Y
CAMP4 Therapeutics Corporation NASDAQ:CAMP	117.81M	28.9%	-21.8%	-11.7%
Unicycive Therapeutics, Inc. NASDAQ:UNCY	49.13M	51.3%	21.3%	N/A
Cue Biopharma, Inc. NASDAQ:CUE	42.21M	-11.8%	-12.7%	10.0%
NRx Pharmaceuticals, Inc. NASDAQ:NRXP	12.96M	21.0%	-16.9%	N/A
Artiva Biotherapeutics, Inc. NASDAQ:ARTV	130.94M	7.6%	-5.1%	N/A
Precision BioSciences, Inc. NASDAQ:DTIL	154.42M	-1.1%	-6.1%	4.6%
Prelude Therapeutics Incorporated NASDAQ:PRLD	141.31M	-20.2%	-14.3%	N/A
Relmada Therapeutics, Inc. NASDAQ:RLMD	94.00M	-1.2%	-15.9%	41.9%
Sutro Biopharma, Inc. NASDAQ:STRO	173.83M	-28.3%	-12.6%	9.6%
Outlook Therapeutics, Inc. NASDAQ:OTLK	18584.18B	8217.2%	1421.2%	288.5%
CEL-SCI Corporation AMEX:CVM	26.99M	-4.0%	-18.7%	8.8%

CAMP4 Therapeutics Corporation Fair Value Envelope

CAMP · NASDAQ

Our analysis suggests that CAMP has a fair value of HIDDEN per share in the Base Case projection. With shares currently trading at $4.37, this represents a potential HIDDEN relative to our calculated worth for CAMP4 Therapeutics Corporation.

HIDDEN

Intrinsic Value

Current Price: $4.37

Related Guides

Blog Categories

Continue your CAMP research with focused valuation guides.

Fundamentals

Decode statement quality and operating durability.

Accounting

Interpret line items with cleaner analytical framing.

Forecasting

Translate historical performance into forward scenarios.

Reference

Use practical frameworks for statement-led valuation.

Research Paths

Pick your next lens

Snapshot

Start with context, operating signals, and key market metrics.

Value Model

Stress test fair value across bear, base, and bull assumptions.

Statements

Validate revenue quality, margins, and balance sheet durability.

Earnings Call

Read management commentary and compare it with reported outcomes.

Dividends

Check payout sustainability and long-term distribution behavior.

Analyst Expectations

Review consensus spread and where estimate risk is concentrated.